Home   Vaccination Schedule

Vaccination Schedule

Recommended Immunization Schedule for Persons Age 0 Through 18 Years

United States, 2013

MMWR version also serves as a text-only for screen-reader devices.

These recommendations must be read with the footnotes that follow. For those who fall behind or start late, provide catch-up vaccination at the earliest opportunity as indicated by the green bars in tables below. To determine minimum intervals between doses, see the catch-up schedule. School entry and adolescent vaccine age groups are 4-6 yrs and 11-12 yrs.

Birth to 15 Months
Vaccine Birth 1 mo 2 mos 4 mos 6 mos 9 mos 12 mos 15 mos
Hepatitis B1 (HepB) ←1st dose→ ←2nd dose→ ←3rd dose→
Rotavirus2(RV)RV-1 (2-dose series); RV-5 (3-dose series) ←1st dose→ ←2nd dose→ See footnote 2
Diphtheria, tetanus, & acellular pertussis3(DTaP: <7 yrs) ←1st dose→ ←2nd dose→ ←3rd dose→ ←4th dose→
Tetanus, diphtheria, & acellular
pertussis4 (Tdap: ≥7 yrs)
Haemophilus influenzae type b5 (Hib) ←1st dose→ ←2nd dose→ See footnote 5 ←3rd or 4th dosesee footnote 5
Pneumococcal conjugate6a,c (PCV13) ←1st dose→ ←2nd dose→ ←3rd dose→ ←4th dose→
Pneumococcal polysaccharide6b,c(PPSV23)
Inactivated poliovirus7 (IPV)(<18years) ←1st dose→ ←2nd dose→ ←3rd dose→
Influenza8(IIV; LAIV)
2 doses for some: see footnote 8
Annual vaccination (IIV only)
Measles, mumps, rubella9
(MMR)
←1st dose→
Varicella10 (VAR) ←1st dose→
Hepatitis A11 (HepA) ←2 dose series, see footnote 11
Human papillomavirus12
(HPV2: females only; HPV4: males and females)
Meningococcal13 (Hib-MenCY ≥ 6 wks; MCV4-D≥9 mos; MCV4-CRM ≥ 2 yrs.) see footnote 13

Range of recommended ages for all children Range of recommended ages for catch-up immunization Range of recommended ages for certain high-risk groups Range of recommended ages during which catch-up is encouraged and for certain high-risk groups Not routinely recommended

18 Months to 18 Years
Vaccine 18 mos 19-23 mos 2-3 yrs 4-6 yrs 7-10 yrs 11-12 yrs 13-15 yrs 16-18 yrs
Hepatitis B1 (HepB) ←3rd dose→
Rotavirus2(RV)RV-1 (2-dose series); RV-5 (3-dose series)
Diphtheria, tetanus, & acellular pertussis3(DTaP: <7 yrs) ←4th dose→ ←5th dose→
Tetanus, diphtheria, & acellular
pertussis4 (Tdap: ≥7 yrs)
(Tdap)
Haemophilus influenzae type b5 (Hib)
Pneumococcal conjugate6a,c (PCV13)
Pneumococcal polysaccharide6b,c (PPSV23)
Inactivated poliovirus7 (IPV)(<18years) ←3rd dose→ ←4th dose→
Influenza8(IIV; LAIV)
2 doses for some: see footnote 8
Annual vaccination (IIV only) Annual vaccination (IIV or LAIV)
Measles, mumps, rubella9
(MMR)
←2nd dose→
Varicella10 (VAR) ←2nd dose→
Hepatitis A11 (HepA) ←2 dose series, see footnote 11
Human papillomavirus12
(HPV2: females only; HPV4: males and females)
(3 dose series)
Meningococcal13 (Hib-MenCY ≥ 6 wks; MCV4-D≥9 mos; MCV4-CRM ≥ 2 yrs.) see footnote 13 ←1st dose→ booster

Note: The above recommendations must be read along with the footnotes of this schedule.

For additional guidance for use of the vaccines described in this publication, see the ACIP Recommendations.